Literature DB >> 15574152

Surgical management of lung cancer in Western Australia in 1996 and its outcomes.

Kym Mina1, Michael J Byrne, Gerard Ryan, Lin Fritschi, Mark Newman, David Joseph, Chris Harper, Evan Bayliss, Marlene Kolybaba, Konrad Jamrozik.   

Abstract

BACKGROUND: All cases of lung cancer diagnosed in Western Australia in 1996 in which surgery was the primary treatment, were reviewed. Reported herein are the characteristics of the patients, the treatment outcomes and a comparison of the management undertaken with that recommended by international guidelines.
METHODS: All patients with a new diagnosis of lung cancer in Western Australia in the calendar year of 1996 were identified using two different population-based registration systems: the Western Australian (WA) Cancer Registry and the WA Hospital Morbidity Data System. A structured questionnaire on the diagnosis and management was completed for each case. Date of death was determined through the WA Cancer Registry.
RESULTS: Six hundred and sixty-eight patients with lung cancer were identified; 132 (20%) were treated with surgery. Lobectomy was the most frequently performed procedure (71%), followed by pneumonectomy (19%). Major complications affected 23% of patients. Postoperative mortality was 6% (3% lobectomy, 12% pneumonectomy). At 5 years the absolute survival was as follows for stage I, II, IIIA, IIIB, respectively: 51%, 45%, 12%, 5%.
CONCLUSIONS: Investigations and choice of surgery in WA in 1996 reflect current international guidelines. The survival of patients with resectable lung cancer remains unsatisfactory.

Entities:  

Mesh:

Year:  2004        PMID: 15574152     DOI: 10.1111/j.1445-1433.2004.03271.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  4 in total

1.  Atrial resection for lung cancer: morbidity, mortality, and long-term follow-up.

Authors:  Andreas Kuehnl; Michael Lindner; Hans-Martin Hornung; Hauke Winter; Karl-Walter Jauch; Rudolf A Hatz; Christian Graeb
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  The 30-day mortality and hospital mortality after chest surgery described in the annual reports published by the Japanese Association for Thoracic and Cardiovascular Surgery.

Authors:  Hidetaka Uramoto; Meinoshin Okumura; Shunsuke Endo; Fumihiro Tanaka; Hiroyasu Yokomise; Munetaka Masuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-02-06

3.  Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude.

Authors:  Trond-Eirik Strand; Hans Rostad; Ronald A M Damhuis; Jarle Norstein
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

4.  The dark side of the moon: impact of moon phases on long-term survival, mortality and morbidity of surgery for lung cancer.

Authors:  A Kuehnl; M Herzog; M Schmidt; H-M Hornung; K-W Jauch; R A Hatz; C Graeb
Journal:  Eur J Med Res       Date:  2009-04-16       Impact factor: 2.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.